Antisense and sensibility

被引：65

作者：

Dove, A

机构：

来源：

NATURE BIOTECHNOLOGY | 2002年 / 20卷 / 02期

关键词：

D O I：

10.1038/nbt0202-121

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

It took a leap of faith for researchers to believe that antisense technology might lead to novel medicines, but that commitment could soon pay off.

引用

收藏

页码：121 / 124

页数：4

相关论文

共 4 条

[1] Isis and antisense face crucial test without Novartis
Dove, A
[J]. NATURE BIOTECHNOLOGY, 2000, 18 (01) : 19 - 19
[2] Analysts: Isis-Lilly deal validates antisense
Niiler, E
[J]. NATURE BIOTECHNOLOGY, 2001, 19 (10) : 898 - 899
[3] SAYDA ME, 2001, NATURE, V411, P494
[4] Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression
Tyler, BM
Jansen, K
McCormick, DJ
Douglas, CL
Boules, M
Stewart, JA
Zhao, LH
Lacy, B
Cusack, B
Fauq, A
Richelson, E
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 7053 - 7058